How many institutions own BCTX stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own BCTX shares is 20, representing 9.66% of the company's common stock.

Who are the major shareholders selling BriaCell Therapeutics Corp. stock?

ADVISORY SERVICES NETWORK, LLC, in the last quarter, reduced its stake in BCTX by -100% restricting it's holding to 0 shares of worth nearly -. LYNWOOD CAPITAL MANAGEMENT INC. also lessened -100% of the BCTX shares from its portfolio, reducing its holding to 0 shares of worth -. BANK OF MONTREAL /CAN/ also shunned BCTX shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying BCTX stock?

As per its latest 13F filing, ADVISORY SERVICES NETWORK, LLC increased its stake in BCTX by 100% in the last quarter. The institutional holder raised its holding to 300 shares having worth more than $1.76K. N/A also added N/A more shares of BCTX to its portfolio, raising its holding to - shares of worth -. N/A also increased its BCTX shares holding by N/A which brought its holding to - shares worth -.

BCTX's major insiders: who are they?

The insider with the most stakes in BCTX is Lustig Marc , at the company. Additionally, BCTX stock is highly held by Chairman Bondarenko Jamieson and President, CEO Williams William V. among others.

Did an insider recently sell BCTX stock?

Company executives, directors, and other insiders own 2.55% percent of BriaCell Therapeutics Corp.'s stock. Within the last six months, there have been 0 transaction(s) in which BCTX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Which insider recently purchased BCTX stock?

There have been 0 transaction(s) during the past 6-months in which BriaCell Therapeutics Corp. insiders have bought stock, totalling 0 shares

How much of BCTX does insiders own?

Around 0 BriaCell Therapeutics Corp. shares are held by insiders, which represents about 2.55% of BCTX stock.

Who is the insider with the largest stake?

BCTX , Lustig Marc holds the largest portfolio of the company's shares. BCTX shares owned by Lustig total nearly 902.94 thousand.

Which institution holds the most shares in BCTX?

ROSENBERG MATTHEW HAMILTON is the largest institutional owner in BCTX which holds 12 shares worth $34.00 or 0% of the total BCTX shares outstanding followed by ADVISORY SERVICES NETWORK, LLC with ownership of 0 shares representing 0% of the BCTX ownership. ADVISORY SERVICES NETWORK, LLC is the third largest stakeholder with 300 shares or 0% of the ownership worth more than $1.76K.

Is BriaCell Therapeutics Corp. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the BCTX is concerned, it is a stock which is not optionable.

Is there a short position on BCTX's shares?

Number of BCTX shares short is 92.14K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding BCTX shares are there?

As of today, 1.88M shares of BCTX are outstanding.

Is there many float in BCTX stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, BCTX has 1.56M shares in float.

BCTX short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for BCTX is 1.3.

Stock Ideas

BCTX Stock Ownership Breakdown

NASDAQ : BCTX

BriaCell Therapeutics

$4.34

0.53+13.91%

At Close 4:00 PM

62.83

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares5.25

Short Percent Of Float5.29

Shares Outstanding1.88M

Shares Float1.56M

Shares Short92.14K

Short Ratio1.3

5.29%

Short % of Float

5.25%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

2.55% Percentage of Shares held by All Insiders

9.66% Percentage of Shares held by All Institutions

9.91% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 9.66% of BCTX shares are held by financial institutions. ROSENBERG MATTHEW HAMILTON is the top corporate investor, holding 12 shares valued at $34.00. A 0% stake in BriaCell Therapeutics Corp. is owned by the company. ADVISORY SERVICES NETWORK, LLC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2024	ROSENBERG MATTHEW HAMILTON	0%	12	34	0	0
Mar 31, 2024	ADVISORY SERVICES NETWORK, LLC	0%	0	-	-300	-100.00%
Dec 31, 2023	ADVISORY SERVICES NETWORK, LLC	0%	300	1.76K	300	+100.00%
Dec 31, 2023	ROSENBERG MATTHEW HAMILTON	0%	12	70	0	0
Dec 31, 2023	LYNWOOD CAPITAL MANAGEMENT INC.	0%	0	-	-1.58M	-100.00%
Sep 30, 2023	BANK OF MONTREAL /CAN/	0%	0	-	-34.63K	-100.00%
Sep 30, 2023	ROYAL BANK OF CANADA	0%	0	-	-3.6K	-100.00%
Sep 30, 2023	NATIXIS	0%	0	-	-90.25K	-100.00%
Sep 30, 2023	K.J. HARRISON & PARTNERS INC	0%	0	-	-34.64K	-100.00%
Sep 30, 2023	HIGHTOWER ADVISORS, LLC	0%	0	-	-16.09K	-100.00%
Sep 30, 2023	SIMPLEX TRADING, LLC	0%	0	-	-39.52K	-100.00%
Sep 30, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-1.39K	-100.00%
Sep 30, 2023	LYNWOOD CAPITAL MANAGEMENT INC.	10.2%	1.58M	-	-1.43K	-0.09%
Sep 30, 2023	BELVEDERE TRADING LLC	0%	0	-	-3.69K	-100.00%
Sep 30, 2023	ADVISOR GROUP HOLDINGS, INC.	0%	0	-	-32	-100.00%
Sep 30, 2023	SUMMIT TRAIL ADVISORS, LLC	0%	0	-	-35K	-100.00%
Sep 30, 2023	CAPTION MANAGEMENT, LLC	0%	0	-	-100K	-100.00%
Sep 30, 2023	CONCORD WEALTH PARTNERS	0%	0	-	-15.28K	-100.00%
Sep 30, 2023		0%	0	-	-12.05K	-100.00%
Sep 30, 2023	REDMOND ASSET MANAGEMENT, LLC	0%	0	-	-137.69K	-100.00%
Sep 30, 2023	ROSENBERG MATTHEW HAMILTON	0%	12	-	0	0
Sep 30, 2023	WASATCH ADVISORS LP	0%	0	-	-612.09K	-100.00%
Sep 30, 2023	MORGAN STANLEY	0%	0	-	-75.23K	-100.00%
Sep 30, 2023	NATIONAL BANK OF CANADA /FI/	0%	0	-	-2.5K	-100.00%

Insiders

Among the BCTX insiders holding of 2.55% of the stake in company, LUSTIG MARC, , holds the largest shares of 902.94K. BONDARENKO JAMIESON, Chairman, is the second largest BCTX insider with ownership of 169.86K shares. WILLIAMS WILLIAM V., President, CEO, stands third with possession of 29.8K shares of that stake.

Insiders	Designation	Shares Held
LUSTIG MARC		902.94K
BONDARENKO JAMIESON	Chairman	169.86K
WILLIAMS WILLIAM V.	President, CEO	29.8K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
May 14, 2024	LUSTIG MARC	PURCHASE	2.11	902.94K	1.91M	902.94K
Dec 28, 2022	BONDARENKO JAMIESON	PURCHASE	4.58	28K	128.24K	169.86K
Dec 23, 2022	WILLIAMS WILLIAM V.	PURCHASE	1.94	2.53K	4.91K	29.8K
Dec 20, 2022	BONDARENKO JAMIESON	PURCHASE	5.35	22K	117.7K	141.86K

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.